Pharma stock under pressure: Viela Bio Inc (NASDAQ: VIE)
Viela Bio Inc (NASDAQ: VIE), a clinical-stage biotechnology company engaged in the research and development of treatments for severe inflammation and autoimmune diseases, stock fell…
Viela Bio Inc (NASDAQ: VIE), a clinical-stage biotechnology company engaged in the research and development of treatments for severe inflammation and autoimmune diseases, stock fell…
Viela Bio Inc (NASDAQ: VIE) stock surged over 9.3% on 26th March, 2020 (as of 12:48 pm GMT-4; Source: Google finance) after the company in…
Viela Bio Inc (NASDAQ: VIE) stock continued its bearish momentum on Jan 21st, 2020 (as of 11:57 am GMT-5; Source: Google finance) after falling 14.57%…
Viela Bio Inc (NASDAQ: VIE) stock surged over 19.92% on 17th December, 2019 (Source: Google finance) after the company received the buy rating from the…